Introduction
An array of 'omics' terms has bloomed in the biomedical jargon in the last decade, including genomics, epigenomics, transcriptomics, proteomics, phenomics and metabolomics to name a few examples. The impact of the 'omics' era is noticeable in almost every research field, and the neurosciences are not an exception. Neuroscientists are starting to implement global strategies to answer traditional but still far from wellunderstood questions, such as how neuronal circuits are formed during embryonic development, how a memory is formed at the molecular and cellular levels, how a neurodegenerative process is ignited in the neuron, or how the environment can predispose an individual to behave in a particular manner. The focus on individual genes has provided enormous success in the past and still represents the main stream of research, but it is also now showing its limitations. Physiologists long ago reached the conclusion that the brain cannot be explained in terms of individual cells but, rather, in terms of neuronal circuits and cellular ensembles. Similarly, molecular biologists during the last decade have started to address molecular processes as a whole rather than focus on specific genes, leading to the prominent emergence of systems biology. Not a single gene product but a complex gene program accounts for the response to a particular environmental stimulus or intracellular condition. In consequence, the need for global approaches to define the molecular mechanisms involved in brain processes is becoming more widely acknowledged. Such approaches permit the interrogation of any specific experimental perturbation with the maximum possible coverage and minimal researcher's bias. A prime manifestation of this shift is the growing relevance of a relatively new trend in molecular research, as part of systems biology, called functional genomics, which attempts to describe the global dynamics of gene expression and protein networks (Geschwind and Konopka, 2009) . In this review, we will give a brief overview of transcriptomics and functional genomics studies conducted in the hippocampus, and we will discuss the main strategies for interpreting the resulting lists of genes.
Tackling the neural transcriptome
Similar to the molecular biology revolution of a few decades ago, the neurosciences have been lagging behind other biomedical areas, such as cancer biology, in the adoption of transcriptomics and functional genomics approaches ( Figure 1A ). Some reasons for this are the extreme cellular heterogeneity and complexity of the neural tissue; the difficulty, in the case of human studies, in accessing non-fixed brain tissue in the appropriate developmental or disease stage; the general preference of neuroscientists for hypothesis-driven rather than discovery-based approaches; and the relative lower funding that may have in the past delayed the early access to these novel technologies (see reviews by (Geschwind and Konopka, 2009; Nisenbaum, 2002) . Still, the ability to monitor in parallel the expression of tens of thousands genes is extremely attractive and neuroscientists have now widely adopted these powerful technologies.
Diverse methods have been used for transcriptomic profiling in the brain.
Microarray technology, compared with other transcriptomics technologies ( Figure 1B ), is by far the most popular approach because of its early automation and commercial availability at an affordable cost. The early reports indicating poorly overlapping results between different microarray platforms and research groups (Kothapalli et al., 2002; Kuo et al., 2002; Tan et al., 2003) , have been largely surmounted by constant improvements in the design of array platforms (de Reynies et al., 2006) . The most reliable platforms dominate the market, the public repositories of gene expression profiles are exponentially growing ( (Ioannidis et al., 2009) . Additionally, the strong dependence on valid gene annotation in databases limits transcriptome surveys (Asmann et al., 2008) . Until recently, most commercial arrays for mammalian samples only interrogated a fraction of the transcriptome, frequently excluding many neuronally specific expressed genes, as a consequence of a bias in public databases toward more abundant genes for which more information has been compiled. Indeed, the need to detect less abundant neuronal transcripts has fueled the use of alternative technologies (Asmann et al., 2009; Li et al., 2004) . The new generations of arrays can detect rare transcripts and even alternatively spliced mRNA isoforms and non-coding RNAs, permitting a more comprehensive analysis of the brain transcriptome. This is particularly important because breakthrough discoveries in the last decade have revealed that the transcriptome world is much more complex than expected (Carninci et al., 2005; Fejes-Toth et al., 2009; Kim et al., 2010a) .
Although microarrays have dominated the field since 2000, the situation may be changing. Technological advances in the last few years have allowed the strong reemergence of sequencing-based technologies. Although the first attempts to tackle the neural transcriptome were based on large-scale sequencing, they required laborious cDNA library construction and systematic clone sequencing, and in practical terms they were expensive, time-consuming and often accessible only to a few research groups (e.g., serial analysis of gene expression (SAGE), sequencing of subtraction libraries, and massive parallel sequencing (MPSS); for a brief description see (Ginsberg and Mirnics, 2006; ). In contrast, the novel next-generation sequencing platforms allow sequencing of hundreds of millions of base pairs in a single reaction within a few hours at accessible cost (Mardis, 2008) . For instance, the development of RNA-seq (Mortazavi et al., 2008) makes it possible to directly sequence a pool of pre-processed cDNA fragments using little starting material for a few thousand dollars, and it is reasonable to assume that the costs will be reduced even more in the near future. RNA-seq technology presents two important advances compared with microarrays: 1) it does not require previous knowledge of the transcriptome and allows a fully unbiased survey, and 2) it produces a digital count of transcript abundance rather than an analogue non-linear luminescent or fluorescent dye signal. Sequencing-based technologies also open up other interesting methods of investigation into the regulation of the transcriptome that were previously unavailable, such as sequencing-based methylation analysis and ChIP-seq (chromatin immunoprecipitation high-throughput sequencing) (see "Linking transcriptomics with proteomics" section).
We believe that after nearly 15 years, through the work of many authors, transcriptomic techniques have achieved their promise of becoming an essential tool in the neurosciences (Dougherty and Geschwind, 2005) . The hippocampus represents a prime example of the early pitfalls and limitations as well as the current potential for transcriptomics studies in the nervous system. The simultaneous analysis of the expression of tens of thousands of genes can offer access to issues of great complexity, such as the molecular determinants of hippocampal cell identity, the specification of hippocampal circuits and their modification by experience, and the molecular alterations determining the onset and progression of neurological diseases that affect this brain region. In the next sections, we will review some representative experiments and discuss the most recent advances on these questions. The first approach is not affordable for a single laboratory. Either a consortium or a dedicated institution is needed to generate such a volume of anatomical data and to create and maintain a public database that could provide access to this dataset. At the moment there are several public repositories, such as the Allen Brain Atlas, or ABA (Jones et al., 2009; Lein et al., 2007) , GenePaint (Visel et al., 2004) , Brain Gene Expression Map, or BGEM (Magdaleno et al., 2006) , Gene Expression Nervous System Atlas, or GENSAT (Gong et al., 2003) , in which ISH images for several thousand transcripts can be inspected and downloaded (Table 1) . With the exception of BGEM, these databases do not use radioactive riboprobes, which provide better linearity in the signal than colorimetric-based probes (Carter et al., 2010) , and therefore most of these ISH data are qualitative or at best semi-quantitative. Despite this limitation, highthroughput ISH is extraordinarily useful in understanding the connectivity between brain areas since it provides detailed spatial information. As a proof of principle, ABA data have been recently used to identify functional subdomains in the hippocampus and the molecular determinants of their differential connectivity to other brain areas (Dong et al., 2009; Thompson et al., 2008) . It should be noted, however, that because of the very high cell density in the hippocampus, many neuronal genes seem more highly expressed in this area than in other brain regions ( Figure 2A ). This can make the semiquantitative comparison of gene expression levels in colorimetric ISH unreliable.
In contrast, microarray technology provides precise quantitative data and makes genome-wide studies more accessible and cost affordable for individual laboratories. As a result, there have been several attempts to create gene expression maps based on this technology, either for the whole organism (Bono et al., 2003; Su et al., 2004; , the whole brain, or restricted to the hippocampus. Different sampling strategies have been used, from gross hippocampus dissection (Sandberg et al., 2000) to controlled microdissection (typically of CA1, CA3 and DG) (Datson et al., 2004; Lein et al., 2004; Zapala et al., 2005; Zhao et al., 2001) , voxelation, which does not consider natural boundaries among brain areas (Brown et al., 2002) , laser-capture microdissection (LCM) (Bonaventure et al., 2002; Kamme et al., 2003) and cell sorting of fluorescently labeled neurons (Lobo et al., 2006; Sugino et al., 2006) . Overall, these studies show that an increase in sampling resolution is extremely important to properly discriminate cellular subpopulations and, in consequence, functional anatomical units.
Electrophysiological recordings have demonstrated that even adjacent cells with similar morphologies can have remarkably different electrical properties. Thus, it is possible that small, though biologically relevant, changes in gene expression in a specific neuronal population can be overlooked due to a dilution effect from the mRNA pool from the surrounding tissue. In the case of the nervous system, proper interpretation of the gene profiling results frequently requires validation by methods that provide cellular resolution to determine whether the changes affect specific cell types or subpopulations.
Given the remarkable properties of the nervous system, the ultimate challenge would be to define the transcriptome of small neuronal ensembles or even single cells.
A recent and elegant approach to address the issue of cellular heterogeneity in transcriptomic studies in the central nervous system (CNS) has been presented recently by Heintz's team. They genetically labeled the ribosomes from specific neuronal populations with an antigenic tag that enables affinity purification of polysomal mRNAs for microarray experiments. Consequently, only the transcripts engaged in translation in the targeted cellular population were examined . The utility of this approach, referred to as TRAP (translating ribosome affinity purification), was illustrated by the comparative analysis of 24 CNS cell populations, revealing hundreds of differentially expressed genes and identifying cell-specific and enriched transcripts for each population (Doyle et al., 2008) . The improvement in the anatomical resolution of gene expression changes may result not only from refinements in the sampling procedure but also in data processing. Thus, a recent bioinformatics analysis of brain single-cell transcriptomes has been able to resolve two transcriptionally distinct mitochondrial modules, one enriched in neuronal processes and synapses and another one restricted to the cell body (Winden et al., 2009) .
A major conclusion from the analysis of regional brain transcriptomes is that gene expression differences between brain regions are generally relative (differential levels of transcripts) and not absolute (presence or absence of transcripts) (Gray et al., 2004; Sandberg et al., 2000; Zapala et al., 2005) . This observation can explain why the intense initial search for highly specific promoters for different brain regions may have been less successful than expected. The identity of particular brain regions or neuronal circuits seems to be determined more by unique combinations of gene expression levels, defining a "regional-specific signature", rather than by the expression of unique genes.
After retrieving a catalogue of regionally expressed genes, the next step is to find a biological meaning for such regional variation. Interestingly, it is possible to establish correlations between anatomical patterns of expression with developmental and evolutionary histories. Thus, the expression atlas generated by Zapala and colleagues showed that adult expression profiles are a reflection of the embryonic origin of the tissue and revealed that developmental patterning genes, such as the Hox genes, were significantly enriched among the genes that exhibited strong expression differences between distinct brain areas (Zapala et al., 2005) . The study by Sugino and colleagues found a high degree of heterogeneity among neuronal subpopulations affecting genes related to synaptic and carbohydrate metabolism functions. In this group of genes, there was an over-representation of paralog genes, suggesting that gene duplication may be a determinant for cell type diversification (Sugino et al., 2006) .
Another recent study explored the evolution of the synapse by merging data from proteomics and transcriptomics and concluded that the synaptic components with the most variable profiles among different brain areas correlated with a more recent history in evolution and were enriched in signaling pathway components (Emes et al., 2008 ). In conclusion, these studies suggest that evolution and ontogeny are primary forces in determining "regional-specific signatures" that could bring specific functionalities to each brain area.
From neuronal and synaptic markers to functional circuit assembly
During the development of the nervous system, the coordinated and sequential activation of genetic programs related to cell proliferation and differentiation, and synapse formation and maturation leads to the formation of extremely complex and precise neural circuitries with hundreds of millions of synaptic connections. A better understanding of the development of the hippocampus may result from the examination of these genetic programs. Early reports of gene expression profiling during the development of the hippocampus either in vivo (Mody et al., 2001) or in culture models (Dabrowski et al., 2003) provided a first glance into the complexity of the process, revealing the activation of genetic programs related to synaptic transmission, energetic metabolism, signal transduction, and transcriptional regulation among other functions.
Primary cultures of hippocampal neurons have been demonstrated to be a particularly accessible model to study synaptogenesis. These studies have taken different forms. For example, gene expression profiling studies have been used to identify novel proteins involved in synaptogenesis. After an initial screen using transcriptome-wide techniques, a functional test should be carried out to properly assign a specific role for the differentially expressed transcripts in the development of the synapse. Such functional assays can even take a large-scale approach. Thus, Paradis and colleagues coupled a microarray analysis of synapse development in postnatal hippocampus with an RNAi screening in hippocampal cultures (Paradis et al., 2007) . By correlating changes in gene expression with effects on the postsynaptic density, the authors enlarged the list of synaptogenic proteins with five novel proteins, most of them belonging to the cadherin and semaphorin families.
Another viable strategy is to undertake a systems biology approach by integrating transcriptomics with information from other sources. As an example, the study by Valor et al. combined transcriptional profiling using microarrays with electrophysiological recordings using multi-electrode arrays and morphological analysis using conventional immunocytochemistry techniques . The aim of this work was not to identify novel synaptogenic genes but to correlate transcriptional profiles with other properties of hippocampal cultures, such as network firing activity and synapse maturation. Nearly 20% of the core components of the synaptic machinery, as previously defined by mass spectrometry studies (Collins et al., 2006) , exhibited prominent changes in transcription that preceded the coupling of pre-and postsynaptic markers and the onset of spiking activity. Continued expression was followed by maturation of morphology and electrical neuronal networks. Notably, only mature cultures exhibited activity-dependent gene expression, suggesting that the initial genetic program for synapse formation is independent of firing activity.
From immediate-early genes to transcriptome-driven neural remodeling
Arguably the most characteristic and remarkable feature of the nervous system is its plasticity. External stimuli can modify the membrane properties, intracellular signaling cascades and gene expression in individual neurons to modulate the responses to subsequent stimuli, changing the properties of the neuronal circuits in a durable manner.
It is well-known that long-term synaptic plasticity requires de novo synthesis of both RNAs and proteins (Steward and Schuman, 2001 ). The classical description of the succession of events underlying long-term plasticity considers two waves of gene expression that can be dissected by biochemical means (Platenik et al., 2000) .
Immediately after stimulation, there is a first wave of expression consisting of the induction of so-called immediate early genes (IEGs), a diverse group of genes that were first identified by subtractive hybridization methods preceding the development of microarray technology (Loebrich and Nedivi, 2009 ). Several of these IEGs are transcription factors and can therefore play an active role in the initiation of the second wave of gene expression. The effector molecules, responsible for the rearrangement of synaptic connectivity in response to experience, are produced as part of this complex transcriptional response (see (Abraham and Williams, 2008; Loebrich and Nedivi, 2009 ). These events are thought to critically contribute to the acquisition and consolidation of hippocampus-dependent memory (Collingridge and Bliss, 1995) . More than 20 years after the first reports on neuronal activity-driven transcription, a comprehensive and complete picture of the process in molecular terms is still lacking. How the external signal is propagated from the membrane (through the activation of receptors and channels) to the nucleus and how the nuclear activity in turn alters the future synaptic responses remain major outstanding questions in neurobiology.
To gain a global view of the activity-dependent genetic program, several studies have been conducted to generate genome-wide datasets of transcripts induced by different protocols of neuronal stimulation, such as the use of specific receptor agonists or antagonists, electrical stimulation, seizure induction or training in different learning tasks (Altar et al., 2004; Cavallaro et al., 2002; Coba et al., 2008; French et al., 2001; Havik et al., 2007; Hunsberger et al., 2005; Leil et al., 2002; Leil et al., 2003; Levenson et al., 2004; Matsuo et al., 1998; Pegoraro et al., 2010; Ploski et al., 2010; Ryan et al., 2010; Wibrand et al., 2006; Zhang et al., 2007) . A glimpse of the compiled data indicates that dozens to hundreds of genes belonging to a vast variety of functional categories are affected (see for example (Cavallaro et al., 2002; Havik et al., 2007; Hong et al., 2004; Li et al., 2004; Zhang et al., 2009) . Moreover, gene expression analysis demonstrates that the transcriptional response to a particular stimulus is highly dependent on its characteristics, including duration, drug administration or animal training protocols, time of sampling, etc. These procedural differences could explain the apparent low concordance observed in some studies (Wang et al., 2009) .
A successful strategy to extract more meaningful information from these sorts of transcriptomics data is to explore the role of specific upstream transcription factors in The analysis also revealed potential links with the MAPK signaling pathway, chromatin remodeling, local protein synthesis machinery and neurogenesis (Ryan et al., 2010) .
A comparison with previous datasets accessible in public databases can also contribute to extracting additional meaningful information from genome-wide experiments. For example, Park and colleagues conducted a microarray study to determine the temporal gene expression profile in the mouse dentate gyrus in response to LTP induction in hippocampal slices and identified a few hundred genes that responded to stimulation. The chromosomal location of these genes, which encoded proteins involved in various cellular processes including the structure and function of the synapse, revealed that they were grouped in highly conserved clusters, suggesting that genes located in the same cluster might be regulated by the same transcription factors. To support this hypothesis, the authors used the dataset on genome-wide CREB occupancy in response to activity generated using the serial analysis of chromatin occupancy (SACO) technique (Impey et al., 2004) and identified clusters of activityregulated genes that were potentially regulated by CREB. (Flavell et al., 2006; . However, using this approach, it is difficult to distinguish between direct and indirect targets because the genetic manipulation is generally chronic and may allow emergency of compensatory transcriptional effects that mask the direct effects of the inhibition, depletion or overexpression of the transcription factor. Novel techniques based on chromatin immunoprecipitation (ChIP) can provide a solution to these issues by precise genomewide mapping of the binding sites for these transcription factors (Kim et al., 2010b; Tanis et al., 2008 ) (see "Linking transcriptomics with proteomics" section).
From markers of neuropathology to the molecular etiology of neurological and psychiatric diseases
Transcriptomics technology, led by microarray platforms, has the potential for commanding personalized medicine. In cancer research, gene expression profiling has been very successful for molecular diagnosis and prognosis because the presence of certain gene signatures ("disease signatures") can predict particular clinical outcomes (Strauss, 2006) . Translated to the brain, transcriptome profiling can also represent an important asset in neuropathology studies given its potential to unveil the complex genetic and environmental interactions that contribute to neurological or psychiatric diseases and determine their progression (see extensive reviews by (Altar et al., 2009; Mufson et al., 2006) for specific references on transcripomics studies related to Alzheimer's disease (AD), schizophrenia, bipolar disorder, aging, etc). The ability to monitor whole transcriptomes has already allowed the identification of new biomarkers of disease in brain samples from patients and provided testable hypotheses for further study. Hypothesis-generating research is particularly important in this field because the etiology of many neural diseases remains elusive and appears multifaceted. Moreover, the discovery of most psychiatric drugs has been the result of serendipitous clinical observations and the empirical validation of their efficacy, but their molecular mechanisms of action remain largely unknown.
However, brain samples are much more difficult to obtain than tumor samples, given the difficult access to the diseased neural tissue. Post mortem brains represent the main source of samples, but their preservation conditions generally compromise RNA quality. Moreover, given the delay between diagnosis and death in many neural diseases, it is hard to evaluate whether the changes in gene expression observed in patients are related to the etiology of the disease, to its side effects or even to its prolonged treatment. Although this issue severely constrains the clinical use of microarray technology in neurological and psychiatric diseases, modest success has been achieved using gene profiling of peripheral blood in Alzheimer's and Huntington's diseases, Tourette's syndrome, tuberous sclerosis and others (reviewed in (Sharp et al., 2006) . These seminal studies suggest that bringing transcriptomics technologies to clinical labs in hospitals might allow neurologists and psychiatrists in the future to base diagnoses and prognoses on the comparison of expression profiles in samples from patients with defined "disease signatures", similar to what it is now possible in cancer research (Hadd et al., 2005 ). Similar to the studies discussed in previous sections, further inspection of the expression profiles using bioinformatics tools can provide functional meaning and testable hypotheses. For example, a novel algorithm that assumes that co-expressed genes are functionally related (Weighted Gene Coexpression Network Analysis, or WGCNA) was applied to microarray data of the hippocampal CA1 subfield from AD patients. The algorithm was not only able to confirm a number of known key genes in AD but also identified novel ones as putative hubs (i.e., central and highly interconnected gene products that are predicted to be essential in a molecular network system). The study also organized the data into functional categories that pointed to mitochondrial and synaptic disruption as relevant events in the pathophysiology of the disease (Miller et al., 2008) . More recently, a similar approach was used to compare the transcriptional network profiles of the human and the mouse brain, including hippocampal tissue, resulting in the definition of modules of gene co-expression that were preserved between the two species. Interestingly, the study identified among the transcriptional divergences a human-specific correlation of presenilin 1 with oligodendrocyte markers, and a human-specific module that strongly correlated with AD progression and contained several poorly characterized genes likely related to this disease (Miller et al., 2010) . Such network modeling can be useful to clarify the complexities of the molecular dynamics in disease and to identify the most relevant targets for therapeutics in the molecular network.
Linking transcriptomics with proteomics: Toward a systems biology of the hippocampus
Despite the great advances in the field of high-throughput proteomics (reviewed in (Bayes and Grant, 2009; Chen and Yates, 2007; Deutsch et al., 2008; Kline et al., 2009 ), the generalized use of these techniques has been limited primarily due to the large dynamic range of protein abundance that makes quantification and time course analysis technically difficult (Deutsch et al., 2008; Kline et al., 2009) , particularly if compared with microarray experiments. For most genes, there is a good correlation between transcript and protein levels (Cardozo et al., 2003; Chin et al., 2007; Kislinger et al., 2006; Mijalski et al., 2005) . Moreover, interacting proteins or functionally related proteins tend to be co-expressed at the transcript level (Bhardwaj and Lu, 2005; Jansen et al., 2002; Oldham et al., 2006; Oldham et al., 2008; Winden et al., 2009) , suggesting a coordinated regulation of certain processes at the transcriptional level. Consequently, most researchers have taken advantage of the larger accessibility of transcriptomics techniques to make reasonable inferences about the protein world by analyzing transcriptional profiling upon different experimental conditions. Although transcriptomics and proteomics techniques frequently complement each other, there are unique applications for both approaches. Thus, whereas transcriptomics techniques have the important feature of examining non-coding RNAs, proteomics is required to investigate, in a global manner, the posttranslational modifications of pre-existing proteins that control many aspects of neuronal physiology.
These modifications refer primarily to phosphorylations (Collins et al., 2005) , but recent studies have also highlighted the relevance of other posttranslational modifications (Scheschonka et al., 2007; Sharma, 2010) . Proteomics approaches are also needed to investigate protein turnover and subcellular localization because proteins can be purified from specific subcellular organelles or macromolecular complexes using immunoprecipitation and fractionation procedures, providing essential information about the molecular composition of subcellular compartments. Thus, proteomic studies have provided the first opportunity to study the molecular composition of the synapse from a global perspective (Collins et al., 2006) . Combined mass spectrometry and peptide array technology have revealed the complex combinatorial phosphorylation patterns of postsynaptic proteins triggered by the synaptic activation of specific neuronal receptors (Coba et al., 2009) .
These studies have also demonstrated a high degree of interrelatedness between proteins of diverse functions, including different types of receptors, kinases, cytoskeletal components and scaffolding proteins among others. Hence, the activation of a particular receptor promotes the orchestrated modulation of a network of synaptic and extrasynaptic proteins that will initiate different downstream processes, including transcription (Pocklington et al., 2006) . While the activation of the synaptic complexes triggers specific genetic programs in the cell nucleus, the molecular composition and activity of the complex itself would be, in turn, modulated by the activation of specific genetic programs, as discussed in previous sections. This dialogue between the synapses and the nucleus seems to be a fundamental mechanism underlying brain plasticity and cognitive functions and is a target of different disorders that affect the nervous system (Kandel, 2001; . The combination of global transcriptomics and proteomics approaches is therefore essential for being able to listen to both parts of this dialogue and translate it into a meaningful interpretation of brain function.
Novel technical developments may pave the way in this direction. Chromatin immunoprecipitation (ChIP) allows the recovery of DNA from chromatin after crosslinking and precipitation, using specific antibodies against the transcription factor or DNA-interacting protein of interest. This opens up the possibility of mapping DNAprotein binding events in the genome accurately and quantitatively. The immunoprecipitated DNA fragments can be analyzed in four ways: (1) by qPCR for single regulatory region studies (locus-specific ChIP assay), (2) by microarray technology to investigate the binding to a predetermined set of promoters displayed in the array (ChIP on chip), (3) by creating a library that can be sequenced (ChIP-SAGE or ChIP-SACO), and (4) by direct high-throughput sequencing (ChIP-seq), the latter being the most powerful approach to date (see (Schones and Zhao, 2008) for a detailed description of ChIP-related technologies). As an example of the power of this technique, a recent ChIP on chip analysis compared genome occupancy by total CREB and activated CREB (phosphoCREB) in different brain areas after electroconvulsive stimulation (Tanis et al., 2008) . Whereas the number of promoters occupied by total CREB was similar in cortex, hippocampus and striatum, the number of loci occupied by phosphoCREB differed among regions, showing the lowest occupancy in striatum.
Interestingly, phosphoCREB was bound to different promoters in the three regions, suggesting differential CREB functions throughout the brain.
Combining genome-wide occupancy mapping using ChIP for specific transcription factors with transcriptomics analysis allows for correlating gene transcription with local changes in the chromatin of promoters or regulatory sequences, providing unprecedented insight into gene expression mechanisms and DNA/RNA/protein interactions (Karlic et al., 2010; Visel et al., 2009; Welboren et al., 2009) . A first attempt to apply this approach to the hippocampus has been recently reported (Peleg et al., 2010) . In this study, the acquisition of contextual fear conditioning was correlated with an increase in the acetylation level of several histone residues and the induction of a complex gene expression program in the hippocampus.
Importantly, the acquisition of the behavioral task was impaired in aged animals, which also showed a dramatic attenuation of the acetylation of K12 in histone H4 in genes that were induced by the task in young animals, but not in the aged ones.
The full integration of proteomics and transcriptomics would require a detailed description of the upstream signaling pathways that activate each transcription factor in a given condition, a challenging task given the complex cross-talk and the combinatorial contribution of multiple signaling pathways to protein phosphorylation and gene expression (Coba et al., 2009; Coba et al., 2008; Michaelevski et al., 2010) . As a first approach, merging occupancy data for several transcription factors can provide a full landscape of genome-wide gene regulation (Barski et al., 2007) . A recent study described, for the first time, such a landscape in cortical cultures after membrane depolarization. The genome-wide information on the neuronal activity transcriptome obtained by RNA-seq was correlated with the genome-wide mapping of chromatin binding for several proteins: activity-regulated transcription factors (CREB, SRF and NPAS4), the acetyltransferase CBP, the RNA polymerase II and several histone tags (Kim et al., 2010b) . Such descriptions have an enormous potential for changing our current views regarding gene regulation and genome organization. As a proof, the aforementioned work led to the discovery of a novel and unexpected RNA species associated with regulatory enhancers (eRNA), which likely play an important role in activity-driven gene expression.
Perspectives
Global approaches represent an important complement to the traditional reductionist single-gene studies. Whereas single-gene studies are hypothesis-driven, global approaches are hypothesis-generating or discovery-based and therefore have the potential to yield novel insight into brain function and dysfunction. Current techniques allow the relatively easy production of a large volume of transcriptomics and proteomics data. Continuous technical improvements in combination with a reduction of costs, the exponential growth of public databases that archive and organize this information, and the development of novel bioinformatics tools for the analysis of large biological datasets will ensure a new era of progress characterized by the application of interdisciplinary global approaches to the neurosciences (Figure 3 ).
The major challenge for these global approaches is the proper interpretation and analysis of large descriptive datasets of candidate molecules. The lack of immediate experimental validation tools has frequently led to a crude description of genes catalogued by known function (Cao and Dulac, 2001 ). This is especially true for neurogenomic studies because public resources are strongly biased toward the most abundant gene products (overlooking the scarcely expressed neuronal genes), and functional annotations and pathway networks are biased toward extensively studied processes, such as cancer and cell cycle. As a symptom of the difficulty in data interpretation, many publications based on a genome-wide analysis first present a catalogue of altered transcripts or proteins and subsequently step down from the global to the single-gene level to describe in detail the role of one or a few molecules in the examined process or perturbation. Frequently, the selection of the gene for further study is based on previous knowledge, detracting therefore, at least partially, from the utility of the initial global approach. Fortunately, open access to global data may prevent the loss of disregarded information.
This situation has been changing in the last few years thanks to improvements both in the technology for the detection and quantification of changes in gene expression and in the bioinformatics tools available for their analysis. Transcriptomics studies can greatly benefit from data mining, meta-analyses and comparison with datasets from other sources, especially from proteomics and single-protein studies, to formulate new hypotheses and discover emergent properties of the nervous system. Due to the prominent role of the hippocampus in cognition and disease and its relatively accessible structure, this brain region has become a prime target for systems biologybased studies of the nervous system that combine proteomic, transcriptomic and other "-omic" data toward the ambitious goal of understanding brain function. specific citations. For the hippocampus-specific literature, the term "hippocampal" was used because it produced more hits than "hippocampus", probably because of the inclusion of neuronal culture studies. Citations of hippocampal studies have the same profile as the general publications but with a few years of delay, indicating the late implementation of this technology to research in the hippocampus compared to other fields. B. Search of the PubMed database using the terms indicated in the legend box.
Only unequivocal terms were used, and reviews were excluded. In contrast to other transcriptomics technologies, the citations of microarray studies show an exponential profile. Gene expression profiles are represented as heat maps of the genetic signatures for the connectome (full set of neural connections between different brain areas and over development), the proteome (full set of proteins and their interactions in networks), the genome and epigenome (full set of genes and modifications of the chromatin) and the phenome (full set of phenotypes in an organism).
